Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 2,857-2,868 of 10,592
Other study type icon
CompletedNCT06117397

A Text Messaging Intervention to Reduce Perinatal Depression Risk

This study exists to see whether a guided support group is workable and worth testing more broadly. Researchers are trying to understand whether a guided support group can give earlier or clearer feedback during care.

Remote / online
DepressionOtherFrom 16 Years to 45 Years
Countries
United States
Sponsor
University of Massachusetts, Worcester
Condition
Depression
Drug study icon
CompletedNCT04457310

A Translational and Neurocomputational Evaluation of a Dopamine Receptor 1 Partial Agonist for Schizophrenia

This study exists to understand what helps blood tests and biological markers work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

In United States
SchizophreniaDrugFrom 18 Years to 45 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Drug study icon
CompletedNCT02255513

HLD200 for ADHD

This study is completed in the United States. It is testing HLD200 for ADHD.

In United States
ADHDDrugFrom 6 Years to 12 Years
Countries
United States
Sponsor
Ironshore Pharmaceuticals and Development, Inc
Condition
ADHD
Drug study icon
CompletedNCT03605680

A study Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

In United States
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD
Drug study icon
CompletedNCT03605849

A study Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Remote / online
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.